Pöördumine

Dear Competent Authorities,

We are contacting you as your institution is listed among the Competent National Authorities under the International Drug Control Treaties (UNODC, 2024).

As part of the legislative work currently being undertaken in our country, we are conducting a comparative analysis of regulatory frameworks applicable to medical cannabis in other countries. In this context, we would highly appreciate your assistance in clarifying the legal framework in force in your country.

In particular, we would be grateful for information on the following issues:

1. Which operators are authorised to cultivate cannabis for medical purposes? May such authorisation be granted to both public and private sector entities, and under what general conditions?

2. Which government authority is competent to grant licences or permits for the cultivation of cannabis (other than industrial hemp)? Additionally, which authority is responsible for supervising and verifying compliance of the cultivation with the relevant legal requirements? Furthermore, is oversight of the entire process (including the distribution of medical cannabis to pharmacies or hospitals) entrusted to a single supervisory authority, or is responsibility divided among different institutions?

3. What is the maximum permissible content of THC and THC-A in preparations and products derived from industrial hemp in order for them to remain lawful under the applicable legislation? Furthermore, is home cultivation for personal use permitted under national law?

Thank you in advance for your cooperation. We look forward to your response.

Sincerely,